William Meury, Director at Syndax Pharmaceuticals Inc (SNDX), sold 83,000 shares at $20.45 ($1.7M) on 2023-08-02, disclosed to the SEC on 2023-08-03.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.45 | 24,000 | $491K | 28.9% |
| 2 | $20.46 | 24,000 | $491K | 28.9% |
| 3 | $20.46 | 35,000 | $716K | 42.2% |
| Total | $20.46 avg | 83,000 | $1.7M | 100% |
| Filing → |
| AGN | SELL | 2017-12-04 | $4.1M | — | Filing → |
| ACT | SELL | 2014-12-01 | $1.2M | — | Filing → |
| FRX | SELL | 2013-02-08 | $942K | — | Filing → |